Inhibikase Therapeutics - 54 Year Dividend History | IKT
Historical dividend payout and yield for Inhibikase Therapeutics (IKT) since 1971. The current TTM dividend payout for Inhibikase Therapeutics (IKT) as of February 21, 2025 is $0.00. The current dividend yield for Inhibikase Therapeutics as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.226B |
$0.000B |
|
Inhibikase Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing therapeutics for Parkinson's disease and related disorders. The company operates principally in Boston, Massachusetts. Inhibikase Therapeutics Inc. is headquartered in Atlanta, Georgia.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
